PXL/HO/Cir-041/2025-26                                                                                                     Date: 18.07.2025

Hyderabad

Subject: Product Enquiry – Dubai, UAE

We would like to inform our member companies that PHARMEXCIL in receipt of an enquiry about offering ITRACONAZOLE.

Manufacturers offering itraconazole must have WHO Prequalification or SRA approval, while those without must commit to applying for such approval, provide timelines for dossier submission and bioequivalence testing if needed, and ensure affordable, sustainable supply for LMICs as defined by the World Bank.

Product Name: Itraconazole 

Formulation: Tablets/Capsules Dosage Strength: 200mg 

Quantity: 240,422 x 200mg tablets 

Shelf Life: Minimum 18 months from the date of delivery. 

Pharmacopeial reference: Bidder to state the Pharmacopeial reference for the quoted product 

Last date: 21 July 2025, 17:00

Contact:

Jolly Healthcare - Dev Vaidik 

LE JOLLY HEALTHCARE PRIVATE LIMITED 

Comm off: H-163, Malviya Nagar Industrial Area, Jaipur - 302 017, Rajasthan, India

Corp off: 403, Hamsa Building, Ansar Gallery, Al Karama, Dubai (UAE)

Mobile: +91-8003633988,

Landline +91-141-4023838 

Members are requested to take advantage of the same.

With regards,

Raja Bhanu

Director General              

Disclaimer: Members may please note that the above information is circulated on the basis of information received from LE JOLLY HEALTHCARE PRIVATE LIMITED, Dubai, UAE . Members are advised to make their own decisions before finalizing their business transactions.